CD274 and neoplasm: EVs can specifically express immune regulatory molecules such as PD-L1 and CD40 ligands on their surface, facilitating intercellular communication and modulation of the TME through ligand–receptor interactions, thereby promoting tumor progression [208,209,210,211].